Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30862812.
- Also identified by DOI 10.1038/s41467-019-09058-4 and PMC identifier 6414640.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Bacterial persisters are able to tolerate high levels of antibiotics and give rise to new populations. Persister tolerance is generally attributed to minimally active cellular processes that prevent antibiotic-induced damage, which has led to the supposition that persister offspring give rise to antibiotic-resistant mutants at comparable rates to normal cells. Using time-lapse microscopy to monitor Escherichia coli populations following ofloxacin treatment, we find that persisters filament extensively and induce impressive SOS responses before returning to a normal appearance. Further, populations derived from fluoroquinolone persisters contain significantly greater quantities of antibiotic-resistant mutants than those from untreated controls. We confirm that resistance is heritable and that the enhancement requires RecA, SOS induction, an opportunity to recover from treatment, and the involvement of error-prone DNA polymerase V (UmuDC). These findings show that fluoroquinolones damage DNA in persisters and that the ensuing SOS response accelerates the development of antibiotic resistance from these survivors.
Medical subject headings
- Anti-Bacterial Agents
- Drug Resistance, Bacterial
- Escherichia coli
- Ofloxacin
- SOS Response, Genetics